Sinus and Allergy Releif PE

Product NDC
59726-810
11-digit product format
597260810
Labeler code
59726
Product ID
59726-810_34139cfe-b5c8-492f-8bf4-6642a14902ed
Type
HUMAN OTC DRUG
Nonproprietary name
Chlorpheniramine maleate, Phenylephrine HCl
Dosage form
TABLET
Route
ORAL
Labeler
P & L Development, LLC
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2014-02-28
Marketing end
2020-12-31
Substance
CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
Active strength
4 mg/1; mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct59726-810DDiscontinued by firm2026-10-05
excluded packagepackage59726-81059726-810-24DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage59726-810-24d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage59726-810-24f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage59726-810-242ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage59726-810-24a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage59726-810-24cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage59726-810-24cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage59726-810-24302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage59726-810-24ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage59726-810-240efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage59726-810-24ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage59726-810-24367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage59726-810-24557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CHLORPHENIRAMINE MALEATEACTIVE INGREDIENTV1Q0O9OJ9ZSINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJSINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
CHLORPHENIRAMINEACTIVE MOIETY3U6IO1965USINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVSINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEINACTIVE INGREDIENTO7TSZ97GEPSINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61USINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOSINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30SINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
MINERAL OILINACTIVE INGREDIENTT5L8T28FGPSINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4SINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
SODIUM STARCH GLYCOLATE TYPE A CORNINACTIVE INGREDIENTAG9B65PV6BSINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJSINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APSINUS AND ALLERGY RELEIF PE (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1